Wednesday, January 5, 2022

Initial results of a 4th-dose study in Israel show an expected rise in antibodies.


By BY ISABEL KERSHNER from NYT World https://ift.tt/3f6XJjL
Posted by at
Labels:

No comments:

Post a Comment

Subscribe to: Post Comments (Atom)